The National Institutes of Health (NIH) awards the University of Arizona roughly 200 grants totaling about $100 million each year. In 2018 the numbers increased to 266 grants totaling $125,091,695. A large portion of this NIH research funding was awarded to the over 250 scientists included in the University's BIO5 Institute. Here are the top 10 BIO5 NIH grant recipients:Read More
Science Market Update
Tags: biomedical research, Biotech Event, Alzheimer's Research, UAZ, Research Funding, NIH funding, NIH grant, University of Arizona Tucson, UA, cancer research funding, cancer research grant, Asthma research, BioResearch Product Faire™, Cancer Diagnostics, cytomegalovirus, Valley Fever, virus research, BIO5 Institute
Ovarian cancer has a mortality rate of up to 70%. This is partly due to the fact that the disease is rarely detected in its early stages because the symptoms are vague and nonspecific. Currently, there is no accepted screening method for ovarian cancer. Due to the mortality rate, physicians often counsel women at high risk to have their ovaries and fallopian tubes removed as a precaution. Jennifer Barton, director of University of Arizona’s BIO5 Institute wants to change all this. With $863,000 from the United States Army and nearly $500,000 from the NIH in research funding, her plans for a falloposcope that will detect early-stage ovarian cancer is moving forward.Read More
Tags: biomedical research, Biotech Event, UAZ, Research Funding, NIH funding, NIH grant, University of Arizona Tucson, UA, cancer research funding, cancer research grant, ovarian cancer, BioResearch Product Faire™, Cancer Diagnostics, NIDA, BIO5 Institute
The University of Arizona Health Sciences-Banner Health has received the largest National Institute of Health (NIH) grant award in the state’s history. The $60 million, five-year award will fund the university’s All of Us Research Program, which will include Hispanic/Latino and American Indian/Alaskan Native participants and communities.Read More
Valley Fever affects nearly 10,000 people in the United States each year, predominately in the Southwestern states of Arizona and California. This infection, caused by the fungus Coccidioide, affects different people in different ways: some get very ill while others are only mildly affected. However people are affected, there is no vaccine to cure the infection. A team of researchers from the University of Arizona, Tucson recently received a $4.8 million grant from the National Institute of Allergy and Infectious Disease (NIAID) to develop a vaccine for Valley Fever.Read More
Construction of the new Bioscience Research Laboratories (BSRL) building at the University of Arizona, Tucson will soon be entering its final phase. This $107,5000,000 project began in December of 2015 and is expected to be completed in December of this year. The new four story, 100,000-square-foot biomedical building will be located along Cherry Ave, adjacent to the Keating BIO5 and the Medical Research Building. It will house imaging, the CLIA genetics core facility, informatics, and wet lab space.
(Image of the Bioscience Research Building courtesy of University of Arizona)Read More
The National Institute of Health awarded a five year, $7 million grant to Dr. Monica Kraft at the University of Arizona College of Medicine – Tucson. The funding will support a research study titled, “Dysfunction of Innate Immunity in Asthma,” which will seek to improve our understanding of mediators that help control lung inflammation. This in turn may lead to improved therapies for reducing severe asthma attacks.Read More
Highlighting UA Tucson's Summer achievements though was a $43 million award to support at least five years of disease research, both on the basic science and clinic sides. This record breaking grant from this NIH, the largest in Arizona's history, will likely propel UA's ranking further ahead on the 2016 NIH Life Science Funding statistics list. In 2015, UAZ received a total of $75.5 million.
“This is huge for Arizona. Only four academic medical centers across the country were chosen,” said Elizabeth Calhoun, one of the grant’s principal investigators at the UA’s Arizona Health Sciences Center. “Arizona will now have the ability to partake in the next generation of science in a way that they have never had an ability to do."
(University of Arizona campus, courtesy of Wikimedia Commons)
The second was a $11.4 million, five-year project grant from the National Heart, Lung, and Blood Institute which will fund research into the genetics of acute lung disorders. Dr. Joe "Skip" Garcia, the senior vice president of health sciences at the University of Arizona and principal investigator of this study, received this award through the NIH's highly competitive Project Program Grant which encourages collaborative projects between peers with diverse specialties to catalyze innovative results.
"Coming shortly after the announcement of the largest NIH grant ever awarded in the state of Arizona, this award is another reminder of the strength of the UA Health Sciences and the impact our faculty researchers, clinicians and teachers are creating in our state and around the world." ~UA President Ann Weaver Hart
To learn more about life science research developments and discoveries at the University of Arizona, see the left links featuring recently published UA articles previously published on Science Market Update:
The National Cancer Institute is funding a million dollar study at the University of Arizona to help detect ovarian cancer sooner. It is hoped this project will lead to the first effective screening test for a disease that kills 14,000 women a year and often gives little to no warning of its presence until it’s too late.Read More
Tags: University of Arizona, University of Arizona Tucson Research, Arizona, UAZ, Biotechnology Vendor Fair, Research Funding, Tucson, University of Arizona Tucson, UA, ovarian cancer, 2016, cancer reserach, Dr. Jennifer Barton, Optical imaging technology
The time between a patient being admitted to the hospital with an infection and the doctor making an accurate diagnosis needs to be quick so the proper treatment can be prescribed. Sometimes, however, the time between admission and diagnosis can take too long, leading to the infection spreading and causing more damage.Read More